| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |